A global multicenter,randomized,double-blind,placebo -controlled, adaptive designed phase Ⅲ clinical trial to evaluate the efficacy, safety and immunogenicity of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in adults 18 years old and above
عنوان الدراسة
A global multicenter,randomized,double-blind,placebo -controlled, adaptive designed phase Ⅲ clinical trial to evaluate the efficacy, safety and immunogenicity of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in adults 18 years old and above
داعم الدراسة
MOH / CanSino
دواء الدراسة
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
رقم بروتوكول الدراسة
CS-CTP-AD5NCOV-ⅢCo
حالة الدراسة
Rejected
موقع الدراسة
King Fahad Medical City (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.